Back
Protagonist Therapeutics Vs. CVS Health Industry Stock Comparison
Buy
57
PTGX
Protagonist Therapeutics
Last Price:
33.37
Seasonality Move:
14.81%
Sell
37
CVS
CVS Health
Last Price:
60.20
Seasonality Move:
0.42%
Buy
57
Protagonist Therapeutics (PTGX)
is a Buy
Is Protagonist Therapeutics a Buy, Sell or Hold?
- The current Protagonist Therapeutics [PTGX] share price is $33.39. The Score for PTGX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PTGX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
37
CVS Health (CVS)
is a Sell
Is CVS Health a Buy, Sell or Hold?
- The current CVS Health [CVS] share price is $60.22. The Score for CVS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
- CVS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PTGX Stock Price Chart
What is Protagonist Therapeutics's stock price today?
-
The Protagonist Therapeutics share price today is $33.39
The current trend is moderately bullish and PTGX is experiencing slight selling pressure.
CVS Stock Price Chart
What is CVS Health's stock price today?
-
The CVS Health share price today is $60.22
The current trend is relatively stagnant and CVS is experiencing slight buying pressure.
PTGX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.48 | Buy |
| Relative Strength Index (14 RSI): | 60.08 | Buy |
| Chaikin Money Flow: | -119501 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
CVS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.01 | Sell |
| Relative Strength Index (14 RSI): | 51.62 | Buy |
| Chaikin Money Flow: | 2308266 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (55.7 - 60.42) | Buy |
| Bollinger Bands (100): | (60.49 - 77.23) | Sell |
PTGX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.96 | Sell |
| 20-day SMA: | 31.55 | Buy |
| 50-day SMA: | 28.85 | Buy |
| 200-day SMA: | 23.59 | Buy |
| 8-day EMA: | 33.27 | Buy |
| 20-day EMA: | 31.77 | Buy |
| 50-day EMA: | 29.87 | Buy |
| 200-day EMA: | 25.42 | Buy |
CVS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.62 | Sell |
| 20-day SMA: | 58.47 | Buy |
| 50-day SMA: | 61.89 | Sell |
| 200-day SMA: | 70.3 | Sell |
| 8-day EMA: | 60.16 | Buy |
| 20-day EMA: | 59.52 | Buy |
| 50-day EMA: | 62.2 | Sell |
| 200-day EMA: | 69.72 | Sell |
Protagonist Therapeutics Earnings Growth & PTGX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $2.69 per share, an increase this year of $4.32 per share, and a decrease next year of $2.45 per share.
CVS Health Earnings Growth & CVS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.12 per share, an increase next quarter of $0.07 per share, a decrease this year of $1.57 per share, and an increase next year of $0.98 per share.
Protagonist Therapeutics Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
CVS Health Technical Analysis
| Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 7 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 03 | 04 | 05 | 06 | 07 | 10 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||